BioNTech is a biotechnology company based in Germany, renowned for its work in developing and manufacturing innovative therapies, particularly in the field of mRNA technology. Founded in 2008, BioNTech gained global prominence for its role in creating one of the first authorized COVID-19 vaccines in collaboration with Pfizer. The company focuses on personalized cancer immunotherapies and has a pipeline of various mRNA-based therapeutic candidates targeting infectious diseases and other conditions. BioNTech’s advancements represent a significant shift in vaccine development and therapeutics, utilizing the body’s own immune system to combat diseases.
Úspěch mRNA vakcíny od BioNTechu přechází do nové kapitoly zaměřené na léčbu rakoviny. Společnost reportovala pokles zisku na akcii na 1,08 eura, ale překonala tržní očekávání. Příjmy klesly na 1,19…